Our free daily oncology focused e-news service.

Oncology Clinical News

Celldex Announces Completion of Enrollment in Phase 2b Study of Glembatumumab Vedotin in Triple Negative Breast Cancer

(Morningstar) Aug 23, 2017 - Celldex Therapeutics, Inc. announced today that patient enrollment has been completed in the Company's Phase 2b METRIC study of glembatumumab vedotin in patients with metastatic triple negative breast cancers that overexpress gpNMB.

read article

Alliance Foundation Trials Opens Global Trial Investigating First-in-Class Palbociclib in HR+, HER2+ Metastatic Breast Cancer

(Yahoo! Finance) Aug 22, 2017 - The Alliance Foundation Trials, LLC (AFT), in conjunction with Pfizer and six international cancer research groups, today announced the launch of PATINA – a randomized, open-label, Phase 3 clinical study of the cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor palbociclib (also known as IBRANCE®).

read article

Artificial Intelligence Tool Promises Earlier Detection Of Deadly Form Of Skin Cancer

(University of Waterloo [Waterloo, ON, Canada]) Aug 23, 2017 - New technology being developed by researchers at the University of Waterloo and the Sunnybrook Research Institute is using artificial intelligence (AI) to help detect melanoma skin cancer earlier.

read article

Cancer Screening Not Recommended in Patients With VTEs

(Medscape Medical News) Aug 22, 2017 - Venous thromboembolism (VTE) can be the first sign of an occult cancer, but aggressive cancer screening is not worthwhile in individuals who present with a VTE, conclude researchers reporting a new meta-analysis.

read article (free registration required)

Oncology Business and Policy News

Profit Finally In Sight For Gene Therapy Specialist Oxford Bio

(Reuters) Aug 23, 2017 - After 20 years of losses, gene therapy specialist Oxford BioMedica is at last close to achieving its first profit thanks to the success of Novartis with a pioneering cancer treatment.

read article

Astellas Extends Phase III Programme For Rydapt Rival Gilteritinib

(PMLiVE [UK]) Aug 23, 2017 - Astellas has started a fourth phase III trial of acute myeloid leukaemia (AML) drug gilteritinib, a FLT3 inhibitor racing to join Novartis' recently-approved Rydapt on the market.

read article

NCCN Guidelines to be Integrated into the Evinance Decision Support Platform

(NCCN) Aug 23, 2017 - The National Comprehensive Cancer Network® is collaborating with Evinance to integrate the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) into the Evinance Decision Support Platform to allow for point-of-care access to treatment recommendations derived from the NCCN Guidelines®.

read press release

Are You Ready for October 2? Plan Ahead for Key QPP Deadline

(ASCO in Action) Aug 22, 2017 - Oncology practices across the country are currently implementing provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), which established the Quality Payment Program (QPP).

read article

In Comments to CMS, ASCO Outlines Recommendations on Proposed QPP Rule

(ASCO in Action) Aug 22, 2017 - ASCO submitted comments to the Centers for Medicare & Medicaid Services (CMS) on its proposed rule outlining changes to the Quality Payment Program (QPP) for 2018.

read article